Antacids Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025

Nov 2019| FMR542A| Fact Market Research

Report Highlights

Antacids Market – Scope of the Report

Fact.MR’s report on the antacids market provides forecast details and an all-inclusive outlook on the growth and development of the landscape. With historical data from 2017 to 2019, estimated data for 2020, and forecast data up to 2025, in terms of revenue and volume, this study has information on the trends and how they impact the antacids market over the forecast period. This research report offers data on the key trends, along with the micro and macro-economic indicators that have an impact on the antacids market. This report sheds light on how these trends are expected to affect every component in the value chain, from the suppliers to the end users, and how they are likely to influence the market as a whole.

This report is a study on the current scenario, on end user’s requirements, new developments, and the issues faced by the supply chain as a whole in the antacids landscape. It is meant to provide readers with an exclusive view of the antacids market as a whole, and a detailed understanding of the major players in the antacids landscape. This analysis of key players includes data and analytics on product developments and market presence, along with a comparative assessment of the companies, on a variety of parameters.

This study on the global antacids market has drug class, formulation, distribution channel, and region-specific data, along with market size valuation. It also has an in-depth forecast price point assessment of the same. The price index and the impact analysis of key regional and country-wise dynamics, also mentioned in the antacids market report, have been obtained through quotes from stakeholders and experts in the global antacids market. An in-depth analysis on the Y-o-Y growth projections of the antacids market is also included in this report.

Antacids Market – Research Methodology

Data presented in this report on the global antacids market, pertaining to regional- and country-level information of the segments, is estimated though a combination of primary and secondary research, across countries and regions. This collated information is analysed using both, the top-down and the bottom-up approach, along with Porter’s Five Forces analysis, and an analysis of the market attractiveness as well.

This Fact.MR global antacids market’s competition scenario analysis is based on historical data and on current trends in the market, and insights obtained through secondary research. The system of data triangulation is also used for the cross-checking of the collected and analysed data, from both, the supply and the demand side of the antacids market.

For the assessment of market size and volume estimations, data has been gathered from the revenues of leading players, coupled with their production capacities. There are also other qualitative findings and perspectives gathered from interviews with people within the market, including Plant Managers, Business Development Managers / Executives, and CEOs, which has been added to this report on the antacids market. This information has been adhered to by the analysts while developing this report on the global antacids market. Secondary research is leveraged for ascertaining the overall size of the antacids market.

The market viewpoint that is offered in this report on the antacids market considers the impact of the macro-economic factors that are expected to influence the progress of the market. The study includes a section on global pricing analysis, restraint analysis, and an opportunity analysis of the antacids market as well.

This report is designed to serve as an authentic and informative resource, enabling readers to make data-based decisions on the future of businesses in the global antacids market.

  • Table 1 : Global Antacids Market Size (US$ Mn) Forecast, By Drug Class, 2015–2025
  • Table 2 : Global Antacids Market Size (US$ Mn) Forecast, By Formulation, 2020-2025
  • Table 3 : Global Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015–2025
  • Table 4 : Global Antacids Market (US$ Mn) Forecast, By Region, 2015–2025
  • Table 5 : North America Antacids Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 6 : North America Antacids Market Size (US$ Mn) Forecast, by Formulation, 2015–2025
  • Table 7 : North America Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015–2025
  • Table 8 : North America Antacids Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 9 : Europe Antacids Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 10 : Europe Antacids Market Size (US$ Mn) Forecast, by Formulation, 2015–2025
  • Table 11 : Europe Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015 and 2025
  • Table 12 : Europe Antacids Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 13 : Asia Pacific Antacids Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 14 : Asia Pacific Antacids Market Size (US$ Mn) Forecast, by Formulation, 2015–2025
  • Table 15 : Asia Pacific Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015 and 2025
  • Table 16 : Asia Pacific Antacids Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 17 : Latin America Antacids Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 18 : Latin America Antacids Market Size (US$ Mn) Forecast, by Formulation, 2015–2025
  • Table 19 : Latin America Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015–2025
  • Table 20 : Latin America Antacids Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 21 : Middle East and Africa Antacids Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 22 : Middle East and Africa Antacids Market Size (US$ Mn) Forecast, by Formulation, 2015–2025
  • Table 23 : Middle East and Africa Antacids Market Size (US$ Mn) Forecast, By Distribution Channel, 2015 and 2025
  • Table 24 : Middle East and Africa Antacids Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Figure 1 : Global Antacids Market Size (US$ Mn) Forecast, 2015–2025
  • Figure 2 : Market Value Share, By Drug Class (2019)
  • Figure 3 : Market Value Share, By Formulation (2019)
  • Figure 4 : Market Value Share By, Distribution Channel (2019)
  • Figure 5 : Market Value Share, By Region (2019)
  • Figure 6 : Porter’s Five Force Analysis
  • Figure 7 : Global Antacids Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 8 : Global Proton Pump Inhibitor Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 9 : Global H2 Antagonist Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 10 : Global Acid Neutralizer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 11 : Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 12 : Global Antacids Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 13 : Global Antacids Tablet Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 14 : Global Antacids Liquids Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 15 : Global Antacids Powder Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 16 : Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 17 : Global Antacids Market Attractiveness Analysis, By Formulation
  • Figure 18 : Global Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 19 : Global Hospital Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 20 : Global Retail Pharmacies Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 21 : Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
  • Figure 22 : Global Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 23 : Global Antacids Market Value Share, By Region, 2019 and 2025
  • Figure 24 : Global Antacids Market Attractiveness Analysis, By Region Type
  • Figure 25 : North America Antacids Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 26 : North America Antacids Market Attractiveness Analysis, By Country
  • Figure 27 : North America Antacids Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 28 : North America Antacids Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 29 : North America Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 30 : North America Market Value Share Analysis, By Country, 2019 and 2025
  • Figure 31 : North America Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 32 : North America Antacids Market Attractiveness Analysis, By Formulation
  • Figure 33 : North America Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 34 : Europe Antacids Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 35 : Europe Antacids Market Attractiveness Analysis, By Country
  • Figure 36 : Europe Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 37 : Europe Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 38 : Europe Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 39 : Europe Market Value Share Analysis, By Country, 2019 and 2025
  • Figure 40 : Europe Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 41 : Europe Antacids Market Attractiveness Analysis, By Formulation
  • Figure 42 : Europe Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 43 : Asia Pacific Antacids Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 44 : Asia Pacific Antacids Market Attractiveness Analysis, By Country
  • Figure 45 : Asia Pacific Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 46 : Asia Pacific Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 47 : Asia Pacific Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 48 : Asia Pacific Market Value Share Analysis, By Country, 2019 and 2025
  • Figure 49 : Asia Pacific Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 50 : Asia Pacific Antacids Market Attractiveness Analysis, By Formulation
  • Figure 51 : Asia Pacific Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 52 : Latin America Antacids Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 53 : Latin America Antacids Market Attractiveness Analysis, By Country
  • Figure 54 : Latin America Antacids Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 55 : Latin America Antacids Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 56 : Latin America Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 57 : Latin America Market Value Share Analysis, By Country, 2019 and 2025
  • Figure 58 : Latin America Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 59 : Latin America Antacids Market Attractiveness Analysis, By Formulation
  • Figure 60 : Latin America Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 61 : Middle East and Africa Antacids Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
  • Figure 62 : Middle East and Africa Antacids Market Attractiveness Analysis, By Country
  • Figure 63 : Middle East and Africa Market Value Share Analysis, By Drug Class, 2019 and 2025
  • Figure 64 : Middle East and Africa Market Value Share Analysis, By Formulation, 2019 and 2025
  • Figure 65 : Middle East and Africa Antacids Market Value Share Analysis, By Distribution Channel, 2019 and 2025
  • Figure 66 : Middle East and Africa Market Value Share Analysis, By Country, 2019 and 2025
  • Figure 67 : Middle East and Africa Antacids Market Attractiveness Analysis, By Drug Class
  • Figure 68 : Middle East and Africa Antacids Market Attractiveness Analysis, By Formulation
  • Figure 69 : Middle East and Africa Antacids Market Attractiveness Analysis, By Distribution Channel
  • Figure 70 : AstraZeneca, Breakdown of Net Sales (%), by Region, 2019
  • Figure 71 : AstraZeneca, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 72 : Bayer AG, Breakdown of Net Sales (%), by Region, 2019
  • Figure 73 : Bayer AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 74 : Boehringer Ingelheim, Break down of Net Sales (%), by Region, 2019
  • Figure 75 : Boehringer Ingelheim, Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2019
  • Figure 76 : Dr. Reddy’s, Breakdown of Net Sales (%), by Region, 2019
  • Figure 77 : Dr. Reddy’s, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 78 : GlaxoSmithKline, Breakdown of Net Sales (%), by Region, 2019
  • Figure 79 : GlaxoSmithKline, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 80 : Johnson & Johnson, Break down of Net Sales (%), by Region, 2019
  • Figure 81 : Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2019
  • Figure 82 : Pfizer Inc., Breakdown of Net Sales (%), by Region, 2019 (%)
  • Figure 83 : Pfizer Inc., Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 84 : P&G, Breakdown of Net Sales (%), by Region, 2019
  • Figure 85 : P&G, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 86 : Reckitt Benckiser, Breakdown of Net Sales (%), by Region, 2019
  • Figure 87 : Reckitt Benckiser, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 88 : Sanofi, Breakdown of Net Sales (%), by Region, 2019
  • Figure 89 : Sanofi, Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2019
  • Figure 90 : Breakdown of Net Sales (%), by Region, 2019
  • Figure 91 : Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2019
  • Figure 92 : Takeda Pharmaceutical, Break down of Net Sales (%), by Region, 2019
  • Figure 93 : Takeda Pharmaceutical, Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2019
  • Figure 94 : Valeant Pharmaceuticals International, Inc., Break down of Net Sales (%), by Region, 2019
  • Figure 95 : Valeant Pharmaceuticals International, Inc., Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2019

Fact.MR is an independent, pure play market intelligence firm incorporated with an objective to deliver high quality, customized market research solutions that help our clients successfully go to the market equipped with actionable insights capable of impacting crucial business decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report